Company / Return on Assets (ROA)
Arcadia Biosciences, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-107.5%
FY2025
5-year range
-107.5% / -10.6%
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has declined for 4 consecutive years, from -10.6% in FY2021 to -107.5% in FY2025.
Based on SEC 10-K filings.
-107.5% in FY2025 with a 5-year CAGR of -46.7%.
Declined from -78.0% to -107.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -56.8pp
- 5-Year Change
- -46.7pp
- 10-Year Change
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s return on assets (roa) has declined for 4 consecutive years.
- In FY2025, return on assets (roa) decreased 4.0% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -107.5% | -4.0% |
| FY2024 | -103.4% | -32.6% |
| FY2023 | -78.0% | -53.9% |
| FY2022 | -50.7% | -378.2% |
| FY2021 | -10.6% | +82.6% |
| FY2020 | -60.8% | -47.0% |
| FY2019 | -41.4% | +36.7% |
| FY2018 | -65.4% | +44.8% |
| FY2017 | -118.4% | -273.1% |
| FY2016 | -31.7% | -28.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026